Financials
Cash Data
- Monthly Burn
- Burn Trend
- Dilution Risk
- SEC Filing
Key Stats
Upcoming Catalysts
FDA decisions, readouts and PDUFA dates · scored by probability of approval
| Catalyst | Drug / Treatment | Stage | Prob. of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|
VREX Catalyst Timeline
Dated clinical, regulatory and corporate events for Varex Imaging Corporation
Past FDA Catalysts and PDUFA Decisions
How VREX actually traded into and out of each decision
| Date | Drug | Catalyst | Stage | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|
| No matching catalysts | ||||||
Drug Pipeline Intelligence
No drug pipeline
Varex Imaging Corporation is a medical device company. The clinical trials it takes part in test other companies' drugs, so it has no drug pipeline of its own to score.
Clinical Trial Results
Readouts, endpoints and source filings for every VREX program
| Drug Name | Indication | Phase | Date | Trial Results Summary | Title | Source |
|---|
Inside Trades
| Insider | Side | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Kunkel Jay K.Director | Sell | -8,121 15,329 held | $18.48 | 09/14/2026 |
Hedge Fund 13F Activity
Hedge Funds invested in VREX
| Fund | % of Portfolio | Current MV | Shares Owned | Activity |
|---|---|---|---|---|
| No hedge fund reported a 13F position in VREX for Q3 2026. | ||||
Ownership Trends
VREX Short Interest
Shares sold short, counted twice a month.
Options Data
Option Volume
Option Chain Statistics
| Expiry | Call Vol | Put Vol | Vol P/C | Call OI | Put OI | OI P/C | IV Call | IV Call OI-Wtd | IV Call Vol-Wtd | IV Put | IV Put OI-Wtd | IV Put Vol-Wtd |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-20 | ||||||||||||
Real-Time Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last | Vol | OI | Last | Vol | OI | |
| No data available | ||||||
Calls vs Puts by Expiry
Competitive positioning
How VREX ranks across every disease it competes in
VREX News
Varex Imaging and Waygate Technologies Announce Exclusive Partnership to Accelerate the Transformation of Field Radiography to Digital
Varex Imaging and Waygate Technologies have entered an exclusive partnership to advance the transformation of field radiography to digital formats. This collaboration is expected to enhance the efficiency and effectiveness of imaging technologies. The partnership signifies a strategic move towards modernizing radiographic practices.
Read more →Varex Imaging Board of Directors Member, Dr. Jocelyn Chertoff wins RSNA Gold Medal
Dr. Jocelyn Chertoff, a member of Varex Imaging's Board of Directors, has been awarded the RSNA 2026 Gold Medal, the highest honor from the Radiological Society of North America. This award acknowledges her exceptional contributions to radiology, medical education, and imaging advancements. Varex Imaging expresses pride in her achievement and the benefits of her leadership.
Read more →TrueSpectrum™ at Suzhou NDT Innovation Conference
Varex Imaging presented TrueSpectrum™ at the 7th Suzhou NDT Innovation Conference. Senior Application Specialist Jonathan Schock spoke to a full room about photon counting advantages. This method keeps photons at the detector for cleaner images and shorter scans. The company hosted a booth where attendees discussed the technology.
Read more →Teledyne to Acquire Varex Imaging Corporation
Teledyne Technologies has announced its acquisition of Varex Imaging Corporation for $18.90 per share, valuing the deal at approximately $1.1 billion. The transaction, unanimously approved by both companies' boards, aims to enhance Teledyne's healthcare market presence and leverage Varex's advanced X-ray technologies. The acquisition is expected to close in early 2027, pending regulatory and stockholder approvals.
Read more →Varex Announces Financial Results for Third Quarter Fiscal Year 2026
Varex Imaging Corporation reported its financial results for Q3 FY2026, with revenues of $211 million and a non-GAAP gross margin of 37%. The company experienced a year-over-year revenue increase of 4%, driven by strong growth in its Industrial segment. Notably, Varex recovered $17 million in tariffs, positively impacting its gross profit. However, the cancellation of the earnings conference call raises some investor concerns.
Read more →White Paper: Pyxis™ Photon-Counting CT Detection Platform – Simplifying the Integration of Photon-Counting Computed Tomography
Varex Imaging's Pyxis™ platform enhances photon-counting CT (PCCT) technology, providing better spectral imaging and spatial resolution. The platform ensures diagnostic-grade performance by controlling detector linearity and spectral fidelity. This advancement aims to simplify the integration of PCCT in medical imaging.
Read more →Replacing Mechanical Motion in X-ray Imaging: Varex Multi-Beam X-ray (MBX) Technology
Varex Imaging has launched its Multi-Beam X-ray (MBX) technology, revolutionizing X-ray generation by replacing mechanical motion with electronically controlled beams. This advancement allows for faster, more robust imaging systems and enhances image quality. The technology also supports new 3D imaging geometries, appealing to OEMs for next-generation performance.
Read more →Tackling CT artifacts in multi-material parts: TrueSpectrum™ at ECNDT 2026
Varex Imaging presented its TrueSpectrum Imaging technology at ECNDT 2026, addressing the challenge of beam-hardening artifacts in multi-material parts. The method utilizes dual-energy acquisition on a photon-counting detector to enhance image quality without the need for physical filters. This approach improves both interior and exterior imaging from a single scan, increasing efficiency.
Read more →Varex to Present at the Jefferies Global Healthcare Conference
Varex Imaging Corporation announced its participation in the Jefferies Global Healthcare Conference, scheduled for June 3, 2026. Management will engage in a fireside chat presentation at 3:10 pm ET, which will be available via webcast. This event highlights Varex's commitment to sharing insights and developments in the healthcare sector.
Read more →The GigaCT: Advancing Photon-Counting CT for Next-Generation Spectral Imaging
Varex Imaging has launched the GigaCT, a photon-counting CT research system, in collaboration with the Technical University of Munich and Schleifring GmbH. This prototype aims to enhance spectral imaging by providing better spatial resolution and material differentiation. The system features advanced detector technology and a high-speed data architecture.
Read more →Varex Announces Financial Results for Second Quarter Fiscal Year 2026
Varex Imaging Corporation has announced its financial results for the second quarter of fiscal year 2026. The report includes key financial metrics and performance indicators, although specific details are not provided in the text. This announcement is part of the company's ongoing financial disclosures.
Read more →Varex Schedules Second Quarter Fiscal Year 2026 Earnings Release and Conference Call
Varex Imaging Corporation has announced the schedule for its second quarter fiscal year 2026 earnings release, which will take place on May 7, 2026. Following the release, a conference call will be held at 3:00 pm Mountain Time, accessible via webcast and phone. This event underscores Varex's commitment to transparency and investor communication.
Read more →Varex Announces Successful Completion of Debt Refinancing
Varex Imaging Corporation has successfully completed a debt refinancing, entering into a new $490 million Credit Facility. This includes a secured term loan and revolving credit facility, aimed at strengthening the company's balance sheet. The refinancing is expected to reduce annual cash interest expenses significantly, enhancing financial flexibility for future investments.
Read more →Varex Schedules First Quarter Fiscal Year 2026 Earnings Release and Conference Call
Varex Imaging Corporation has announced the schedule for its first quarter fiscal year 2026 earnings release, set for February 10, 2026. Following the release, a conference call will take place at 3:00 PM Mountain Time, which will be accessible via webcast. The call will also be available for replay for a limited time.
Read more →Varex Imaging to Host Manufacturing Day Event for Local College and University Students
Varex Imaging Corporation is hosting a Manufacturing Day event on October 20th for over 40 college students. The event aims to change perceptions about manufacturing careers and will include facility tours, Q&A sessions with engineers, and a robotics demonstration. This initiative is in partnership with the University of Utah Manufacturing Extension Partnership.
Read more →Varex Imaging to Participate in CJS Securities Investor Conference
Varex Imaging Corporation (Nasdaq: VREX) will participate in the CJS Securities 17th Annual New Ideas Summer Conference on July 11, 2017. CFO Clarence Verhoef will lead a fireside chat discussing the company's innovations and contributions to X-ray imaging. Varex is recognized for its extensive experience and range of imaging components.
Read more →Varex Imaging to Exhibit Digital Imaging Components and Software Solutions at European Congress of Radiology
Varex Imaging will display digital imaging components and software at the European Congress of Radiology in Vienna from March 2 to 5. The exhibit features PaxScan DXV detectors, which consume half the power of previous generations, and the MCS 8064 CT replacement tube. These products highlight the company’s focus on low dose performance and lower life cycle costs for medical imaging systems.
Read more →Varex Imaging to Participate in Two Upcoming Investor Conferences
Varex Imaging Corporation will participate in two upcoming investor conferences: the RBC Global Healthcare Conference on February 22, 2017, and the BTIG Fourth Annual Medical Technology, Life Sciences and Diagnostics Conference on March 1, 2017. CFO Clarence Verhoef will lead discussions at both events, providing insights into the company's operations. Webcast access will be available for investors.
Read more →